Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.7K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.2K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steroidal Saponins from the Bulbs of Chinese Onion (<i>Allium chinense</i> G. Don) and Their Antiproliferation Potential.

Journal of agricultural and food chemistry·2026
Same author

Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention.

bioRxiv : the preprint server for biology·2026
Same author

<i>Magnolia officinalis</i> Rehder & E.H.Wilson. Bark Extract and Magnolol Alleviate Allergic Rhinitis via Modulating NF-κB/MAPK Signaling.

Molecules (Basel, Switzerland)·2026
Same author

Improving Preclinical Cancer Drug Development Models to Avoid Clinical Failure.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer.

Frontiers in cell and developmental biology·2026
Same author

Assessing the Complexities of Utilizing BH3 Mimetics for a Senolytic Strategy in Combination with Ionizing Radiation.

Radiation research·2026

Related Experiment Video

Updated: Nov 28, 2025

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.3K

Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance.

Jingwen Xu1, Nipa H Patel2,3, David A Gewirtz2,3

  • 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.

International Journal of Molecular Sciences
|December 1, 2020
PubMed
Summary

The tumor suppressor p53 and autophagy play complex roles in cancer treatment response. Understanding their interplay is crucial for overcoming drug resistance and improving chemotherapy effectiveness.

Keywords:
autophagychemoresistancep53

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.2K

Related Experiment Videos

Last Updated: Nov 28, 2025

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.3K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Chemotherapy and radiation trigger cellular responses like apoptosis, autophagy, and senescence.
  • The tumor suppressor p53 is a key regulator of these processes, often mutated in cancer.
  • Gain-of-function (GOF) p53 mutations can promote drug resistance by affecting p53's tumor-suppressive functions and modulating autophagy.

Purpose of the Study:

  • To explore the complex relationship between p53 and autophagy in the context of cancer therapy.
  • To investigate how p53's function and localization influence autophagy and drug resistance.
  • To highlight the potential of targeting the p53-autophagy axis for novel cancer treatment strategies.

Main Methods:

  • Review of pre-clinical studies on p53, autophagy, and chemotherapy response.
  • Analysis of the role of p53 mutations and compartmentalization in modulating autophagy.
  • Examination of evidence linking p53-autophagy interactions to drug resistance.

Main Results:

  • Autophagy is initially induced by cancer therapies but has multifaceted roles, including promoting survival.
  • p53's function, including GOF mutations, significantly impacts autophagy induction and inhibition.
  • Compartmental localization of p53 influences autophagic processes and potentially tumor response.

Conclusions:

  • The dual role of p53 and its effects on autophagy are critical factors in tumor response to therapy and drug resistance.
  • Current clinical trial designs may not fully account for the complex p53-autophagy interplay.
  • Further research into this interconnection could yield new insights for overcoming multidrug resistance and developing chemosensitization strategies.